Open Payments

University of CO Hospital

Type
Teaching hospital
Where
Arvada, CO
Medicare CCN
060024
Received
$5,432,198 in 150 records, 2021 ($252,701 general, $5,179,497 research)
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2021General payment45$252,701
2021Research payment105$5,179,497

By company

CompanyRecordsAmountYears
SERVIER PHARMACEUTICALS LLC5$3,292,0802021
E.R. Squibb & Sons, L.L.C.20$1,417,5602021
Avita Medical Americas, LLC1$256,6782021
EMD Millipore Corporation7$77,5972021
Orthofix Medical, Inc.8$55,4262021
AngioDynamics, Inc.2$35,3332021
ROCHE MOLECULAR SYSTEMS, INC.14$34,8242021
Vitalant19$33,3012021
Varian Medical Systems, Inc.1$31,3582021
Intuitive Surgical, Inc.3$24,6732021
Aesculap Biologics, LLC2$23,8832021
LENOSS MEDICAL INC1$22,6722021
Skeletal Dynamics Inc1$21,5002021
ACUMED LLC3$20,7692021
Kaneka Medical America LLC1$14,6622021
Integra LifeSciences Corporation2$11,6002021
Premia Spine, Ltd.3$9,6492021
Abbott Laboratories4$7,4112021
HEARTFLOW, INC.2$7,3662021
Siemens Medical Solutions USA, Inc.1$7,2102021
PFIZER INC.1$6,7502021
Eli Lilly and Company5$6,6312021
Aspire Bariatrics, Inc.1$4,1502021
Boehringer Ingelheim France S.A.S.23$2,6212021
Boehringer Ingelheim Pharma GmbH & Co.KG13$1,7152021
Biotest AG1$1,7012021
ModernaTX, Inc.1$1,2802021
AstraZeneca Pharmaceuticals LP2$1,2142021
Smith+Nephew, Inc.1$3702021
FUJIFILM SonoSite, Inc.1$1942021
Olympus America Inc.1$112021

By nature of payment

NatureRecordsAmount
Research payment105$5,179,497
Compensation for services other than consulting, including serving as faculty or as a speaker at a v24$108,301
Grant6$57,810
Education3$35,527
Consulting Fee4$20,139
Long term medical supply or device loan2$20,000
Gift1$4,673
Space rental or facility fees (teaching hospital only)1$3,269
Royalty or License2$2,597
Debt forgiveness2$381

Records

DateCompanyAmountNatureFormProductStudyYear
2021-12-31AngioDynamics, Inc.$18,500EducationIn-kind items and servicesAuryon Laser System 100-120 Vac Device, ET2021
2021-12-31Intuitive Surgical, Inc.$16,260Long term medical supply or device loanIn-kind items and servicesDa Vinci Surgical System Device, SURGERY2021
2021-12-31Intuitive Surgical, Inc.$4,673GiftIn-kind items and servicesDa Vinci Surgical System Device, SURGERY2021
2021-12-31Intuitive Surgical, Inc.$3,739Long term medical supply or device loanIn-kind items and servicesDa Vinci Surgical System Device, SURGERY2021
2021-12-31AstraZeneca Pharmaceuticals LP$14Research paymentIn-kind items and servicesTAGRISSO Drug, Oncology\";A Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tu2021
2021-12-30ROCHE MOLECULAR SYSTEMS, INC.$2,724Research paymentIn-kind items and servicescobas Influenza A/B Nucleic acid test for use on the cobas Liat System Device, Molecular DiagnosticsRD0053982021
2021-12-24Abbott Laboratories$3,300Consulting FeeCash or cash equivalentEnSite Precision Cardiac Mapping System Device, Electrophysiology2021
2021-12-24Abbott Laboratories$1,925Consulting FeeCash or cash equivalentEnSite Precision Cardiac Mapping System Device, Electrophysiology2021
2021-12-21Vitalant$221Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2021
2021-12-17Vitalant$1,430Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2021
2021-12-15Kaneka Medical America LLC$14,662Consulting Fee (12 payments)Cash or cash equivalentLIPOSORBER Device, Lipid Apheresis2021
2021-12-08Vitalant$460Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2021
2021-12-06EMD Millipore Corporation$15,000Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent Device, DIAGNOSTIC TESTING2021
2021-12-06Premia Spine, Ltd.$1,265Research paymentCash or cash equivalentTOPSA Clinical Study to Assess the Safety and Effectiveness of the Premia Spine TOPS System2021
2021-12-03Vitalant$625Compensation for services other than consulting, including serving as faculty or as a speaker at a v (2 payments)Cash or cash equivalent2021
2021-12-02ROCHE MOLECULAR SYSTEMS, INC.$1,284Research paymentIn-kind items and servicescobas Influenza A/B Nucleic acid test for use on the cobas Liat System Device, Molecular DiagnosticsRD0053982021
2021-12-01PFIZER INC.$6,750Research paymentIn-kind items and services2021
2021-12-01Boehringer Ingelheim Pharma GmbH & Co.KG$114Research paymentIn-kind items and servicesOFEV Drug, RESPIRATORYExtension2021
2021-11-30ROCHE MOLECULAR SYSTEMS, INC.$2,724Research paymentIn-kind items and servicescobas Influenza A/B Nucleic acid test for use on the cobas Liat System Device, Molecular DiagnosticsRD0053982021
2021-11-19Vitalant$1,575Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2021
2021-11-17ACUMED LLC$2,500GrantCash or cash equivalent2021
2021-11-01Skeletal Dynamics Inc$21,500GrantCash or cash equivalentGeminus Device, Orthopedic2021
2021-11-01Boehringer Ingelheim Pharma GmbH & Co.KG$116Research paymentIn-kind items and servicesOFEV Drug, RESPIRATORYExtension2021
2021-10-29ROCHE MOLECULAR SYSTEMS, INC.$2,724Research paymentIn-kind items and servicescobas Influenza A/B Nucleic acid test for use on the cobas Liat System Device, Molecular DiagnosticsRD0053982021
2021-10-26Boehringer Ingelheim France S.A.S.$488Research paymentIn-kind items and servicesPh IIb dose finding vs placebo in patients with Obesity2021
2021-10-22Vitalant$2,205Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2021
2021-10-08LENOSS MEDICAL INC$22,672Research paymentCash or cash equivalentAccess & Cavity Creation Kit Device, Spinal SurgeryThe Biological Allograft Chain Tissue Implant & Associated Manual Surgical Instrumentation: A Prospective, Post-Market S2021
2021-10-07Premia Spine, Ltd.$4,229Research paymentCash or cash equivalentTOPSA Clinical Study to Assess the Safety and Effectiveness of the Premia Spine TOPS System2021
2021-10-01Boehringer Ingelheim Pharma GmbH & Co.KG$116Research paymentIn-kind items and servicesOFEV Drug, RESPIRATORYExtension2021
2021-09-28HEARTFLOW, INC.$3,538Research paymentCash or cash equivalentFFRct Device, Coronory100 Analysis : 200 FFRct Analysis : 400 Clinical Studies : 424 PRECISE2021
2021-09-27SERVIER PHARMACEUTICALS LLC$567,600Research paymentIn-kind items and servicesTIBSOVO Drug, ONCOLOGYSTUDY OF ORALLY ADMINISTERED AG-120 IN SUBJECTS WITH ADVANCED SOLID TUMORS, INCLUDING GLIOMA, WITH AN IDH1 MUTATION2021
2021-09-24Vitalant$1,962Compensation for services other than consulting, including serving as faculty or as a speaker at a v (2 payments)Cash or cash equivalent2021
2021-09-20ROCHE MOLECULAR SYSTEMS, INC.$2,724Research paymentIn-kind items and servicescobas Influenza A/B Nucleic acid test for use on the cobas Liat System Device, Molecular DiagnosticsRD0053982021
2021-09-18Aspire Bariatrics, Inc.$4,150Research paymentCash or cash equivalentAspireAssist Device, GastroenterologyPivotal Aspiration with Adjusted Lifestyle2021
2021-09-15ACUMED LLC$15,000GrantCash or cash equivalent2021
2021-09-10Abbott Laboratories$1,934Research paymentIn-kind items and servicesFlexAbility Ablation Catheter Device, ElectrophysiologyLESS-VT2021
2021-09-01Boehringer Ingelheim Pharma GmbH & Co.KG$119Research paymentIn-kind items and servicesOFEV Drug, RESPIRATORYExtension2021
2021-09-01Boehringer Ingelheim France S.A.S.$80Research paymentIn-kind items and servicesPh IIb dose finding vs placebo in patients with Obesity2021
2021-08-30ROCHE MOLECULAR SYSTEMS, INC.$2,724Research paymentIn-kind items and servicescobas Influenza A/B Nucleic acid test for use on the cobas Liat System Device, Molecular DiagnosticsRD0053982021
2021-08-27Vitalant$72Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2021
2021-08-23Olympus America Inc.$11Debt forgivenessIn-kind items and services2021
2021-08-20Vitalant$2,825Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2021
2021-08-08Boehringer Ingelheim France S.A.S.$34Research paymentIn-kind items and servicesPh IIb dose finding vs placebo in patients with Obesity2021
2021-08-08Boehringer Ingelheim France S.A.S.$34Research paymentIn-kind items and servicesPh IIb dose finding vs placebo in patients with Obesity2021
2021-08-08Boehringer Ingelheim France S.A.S.$34Research paymentIn-kind items and servicesPh IIb dose finding vs placebo in patients with Obesity2021
2021-08-08Boehringer Ingelheim France S.A.S.$34Research paymentIn-kind items and servicesPh IIb dose finding vs placebo in patients with Obesity2021
2021-08-08Boehringer Ingelheim France S.A.S.$34Research paymentIn-kind items and servicesPh IIb dose finding vs placebo in patients with Obesity2021
2021-08-06Integra LifeSciences Corporation$1,600GrantCash or cash equivalentMAYFIELD Device, PRECISION TOOLS & INSTRUMENTS2021
2021-08-03E.R. Squibb & Sons, L.L.C.$100,188Research paymentCash or cash equivalentOPDIVO Biological, OncologyPhase III Adjuvant Melanoma Stage II B C Opdivo Mono2021
2021-08-02SERVIER PHARMACEUTICALS LLC$794,640Research paymentIn-kind items and servicesTIBSOVO Drug, ONCOLOGYSTUDY OF ORALLY ADMINISTERED AG-120 IN SUBJECTS WITH ADVANCED SOLID TUMORS, INCLUDING GLIOMA, WITH AN IDH1 MUTATION2021
2021-08-02SERVIER PHARMACEUTICALS LLC$567,600Research paymentIn-kind items and servicesTIBSOVO Drug, ONCOLOGYSTUDY OF ORALLY ADMINISTERED AG-120 IN SUBJECTS WITH ADVANCED SOLID TUMORS, INCLUDING GLIOMA, WITH AN IDH1 MUTATION2021
2021-08-01Boehringer Ingelheim Pharma GmbH & Co.KG$119Research paymentIn-kind items and servicesOFEV Drug, RESPIRATORYExtension2021
2021-08-01Boehringer Ingelheim France S.A.S.$81Research paymentIn-kind items and servicesPh IIb dose finding vs placebo in patients with Obesity2021
2021-07-30ROCHE MOLECULAR SYSTEMS, INC.$2,724Research paymentIn-kind items and servicescobas Influenza A/B Nucleic acid test for use on the cobas Liat System Device, Molecular DiagnosticsRD0053982021
2021-07-28AngioDynamics, Inc.$16,833EducationIn-kind items and servicesAuryon Laser System 100-120 Vac Device, ET2021
2021-07-27Orthofix Medical, Inc.$2,226Research paymentCash or cash equivalentICON Device, Thoracolumbosacral Pedicle Screw SystemCP-1702SSPM- Study Using the SpinalStim Device Following Lumbar Fusion Surgery2021
2021-07-23Vitalant$1,900Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2021
2021-07-22Abbott Laboratories$252Consulting FeeCash or cash equivalentAMPLATZER Occluders Device, Structural Heart2021
2021-07-16Aesculap Biologics, LLC$22,136Research paymentCash or cash equivalentNOVOCART 3D Device, CARTILAGE REPAIR AND REGENERATIONNOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D)2021
2021-07-16Vitalant$1,938Compensation for services other than consulting, including serving as faculty or as a speaker at a v (5 payments)Cash or cash equivalent2021
2021-07-16Aesculap Biologics, LLC$1,746Research paymentCash or cash equivalentNOVOCART 3D Device, CARTILAGE REPAIR AND REGENERATIONNOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D)2021
2021-07-07Boehringer Ingelheim France S.A.S.$34Research paymentIn-kind items and servicesPh IIb dose finding vs placebo in patients with Obesity2021
2021-07-07Boehringer Ingelheim France S.A.S.$34Research paymentIn-kind items and servicesPh IIb dose finding vs placebo in patients with Obesity2021
2021-07-07Boehringer Ingelheim France S.A.S.$34Research paymentIn-kind items and servicesPh IIb dose finding vs placebo in patients with Obesity2021
2021-07-07Boehringer Ingelheim France S.A.S.$34Research paymentIn-kind items and servicesPh IIb dose finding vs placebo in patients with Obesity2021
2021-07-07Boehringer Ingelheim France S.A.S.$34Research paymentIn-kind items and servicesPh IIb dose finding vs placebo in patients with Obesity2021
2021-07-05EMD Millipore Corporation$15,000Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent Device, DIAGNOSTIC TESTING2021
2021-07-01ModernaTX, Inc.$1,280Research paymentCash or cash equivalentPhase 1, Open-Label, Multicenter, Dose Escalation Study of mRNA-2752, a Lipid Nanoparticle Encapsulated mRNA Encoding Hu2021
2021-07-01Boehringer Ingelheim Pharma GmbH & Co.KG$119Research paymentIn-kind items and servicesOFEV Drug, RESPIRATORYExtension2021
2021-07-01Boehringer Ingelheim France S.A.S.$81Research paymentIn-kind items and servicesPh IIb dose finding vs placebo in patients with Obesity2021
2021-06-30HEARTFLOW, INC.$3,828Research paymentCash or cash equivalentFFRct Device, Coronory100 Analysis : 200 FFRct Analysis : 400 Clinical Studies : 424 PRECISE2021
2021-06-29Siemens Medical Solutions USA, Inc.$7,210GrantIn-kind items and services2021
2021-06-29ROCHE MOLECULAR SYSTEMS, INC.$2,724Research paymentIn-kind items and servicescobas Influenza A/B Nucleic acid test for use on the cobas Liat System Device, Molecular DiagnosticsRD0053982021
2021-06-25Vitalant$3,295Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2021
2021-06-24Boehringer Ingelheim Pharma GmbH & Co.KG$278Research paymentIn-kind items and servicesOFEV Drug, RESPIRATORYExtension2021
2021-06-21Avita Medical Americas, LLC$256,678Research paymentCash or cash equivalentRECELL Device, Mechanical and Enzymatic Autologous Skin Processor For Cell Suspension, With ApplicatorStudy of delivery of gene-modified skin cells to patients with epidermolysis bullosa.2021
2021-06-17FUJIFILM SonoSite, Inc.$194EducationIn-kind items and servicesSonoSite Edge II Device, Medical Device2021
2021-06-11Vitalant$1,124Compensation for services other than consulting, including serving as faculty or as a speaker at a v (2 payments)Cash or cash equivalent2021
2021-06-08Orthofix Medical, Inc.$20,205Research paymentCash or cash equivalentM6-C Device, Prosthesis, Intervertebral DiscM6-C Post Approval Study (PAS)- CA-C0042021
2021-06-06Boehringer Ingelheim France S.A.S.$178Research paymentIn-kind items and servicesPh IIb dose finding vs placebo in patients with Obesity2021
2021-06-03E.R. Squibb & Sons, L.L.C.$19,774Research paymentCash or cash equivalentPhase I II TIM3 FIH Monotherapy Nivo Combination in advanced solid tumors2021
2021-06-01Boehringer Ingelheim Pharma GmbH & Co.KG$123Research paymentIn-kind items and servicesOFEV Drug, RESPIRATORYExtension2021
2021-06-01Boehringer Ingelheim France S.A.S.$83Research paymentIn-kind items and servicesPh IIb dose finding vs placebo in patients with Obesity2021
2021-05-28ROCHE MOLECULAR SYSTEMS, INC.$2,724Research paymentIn-kind items and servicescobas Influenza A/B Nucleic acid test for use on the cobas Liat System Device, Molecular DiagnosticsRD0053982021
2021-05-26Boehringer Ingelheim France S.A.S.$509Research paymentIn-kind items and servicesPh IIb dose finding vs placebo in patients with Obesity2021
2021-05-24EMD Millipore Corporation$15,000Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent Device, DIAGNOSTIC TESTING2021
2021-05-20Orthofix Medical, Inc.$7,538Research paymentCash or cash equivalentICON Device, Thoracolumbosacral Pedicle Screw SystemCP-1702SSPM- Study Using the SpinalStim Device Following Lumbar Fusion Surgery2021
2021-05-20Orthofix Medical, Inc.$3,084Research paymentCash or cash equivalentICON Device, Thoracolumbosacral Pedicle Screw SystemCP-1702SSPM- Study Using the SpinalStim Device Following Lumbar Fusion Surgery2021
2021-05-20Vitalant$1,455Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2021
2021-05-18Orthofix Medical, Inc.$10,926Research paymentCash or cash equivalentM6-C Device, Prosthesis, Intervertebral DiscM6-C Post Approval Study (PAS)- CA-C0042021
2021-05-18E.R. Squibb & Sons, L.L.C.$1,280Research paymentCash or cash equivalentPh II Study Gastric 1L, multi-cohort all comers lag3 nivo2021
2021-05-10Eli Lilly and Company$65Research paymentIn-kind items and servicesA RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, PHASE 3 STUDY OF BARICITINIB IN PATIENTS WITH SYSTEMIC L2021
2021-05-06Integra LifeSciences Corporation$10,000GrantCash or cash equivalentMICROFRANCE Device, PRECISION TOOLS & INSTRUMENTS2021
2021-05-05Boehringer Ingelheim France S.A.S.$176Research paymentIn-kind items and servicesPh IIb dose finding vs placebo in patients with Obesity2021
2021-05-01Boehringer Ingelheim Pharma GmbH & Co.KG$121Research paymentIn-kind items and servicesOFEV Drug, RESPIRATORYExtension2021
2021-05-01Boehringer Ingelheim France S.A.S.$82Research paymentIn-kind items and servicesPh IIb dose finding vs placebo in patients with Obesity2021
2021-04-30Eli Lilly and Company$50Research paymentIn-kind items and servicesA STUDY OF TIRZEPATIDE (LY3298176) ONCE A WEEK VERSUS INSULIN GLARGINE ONCE A DAY IN PARTICIPANTS WITH TYPE 2 DIABETES A2021
2021-04-28ROCHE MOLECULAR SYSTEMS, INC.$2,724Research paymentIn-kind items and servicescobas Influenza A/B Nucleic acid test for use on the cobas Liat System Device, Molecular DiagnosticsRD0053982021
2021-04-23Vitalant$6,640Compensation for services other than consulting, including serving as faculty or as a speaker at a v (4 payments)Cash or cash equivalent2021
2021-04-20Orthofix Medical, Inc.$3,942Research paymentCash or cash equivalentICON Device, Thoracolumbosacral Pedicle Screw SystemCP-1702SSPM- Study Using the SpinalStim Device Following Lumbar Fusion Surgery2021
2021-04-16E.R. Squibb & Sons, L.L.C.$9,159Research paymentCash or cash equivalentPh I IIA FIH mono& combo Tx Solid Tumor2021
2021-04-15Orthofix Medical, Inc.$4,748Research paymentCash or cash equivalentPhysio-Stim Device, Stimulator, Bone Growth, Non-InvasiveCP-1703 CSPM- Study Using the CervicalStim Device Following Cervical Fusion2021
2021-04-14AstraZeneca Pharmaceuticals LP$1,200Research paymentCash or cash equivalentTAGRISSO Drug, Oncology\";A Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tu2021
2021-04-12SERVIER PHARMACEUTICALS LLC$794,640Research paymentIn-kind items and servicesTIBSOVO Drug, ONCOLOGYSTUDY OF ORALLY ADMINISTERED AG-120 IN SUBJECTS WITH ADVANCED SOLID TUMORS, INCLUDING GLIOMA, WITH AN IDH1 MUTATION2021
2021-04-12SERVIER PHARMACEUTICALS LLC$567,600Research paymentIn-kind items and servicesTIBSOVO Drug, ONCOLOGYSTUDY OF ORALLY ADMINISTERED AG-120 IN SUBJECTS WITH ADVANCED SOLID TUMORS, INCLUDING GLIOMA, WITH AN IDH1 MUTATION2021
2021-04-08Orthofix Medical, Inc.$2,752Research paymentCash or cash equivalentICON Device, Thoracolumbosacral Pedicle Screw SystemCP-1702SSPM- Study Using the SpinalStim Device Following Lumbar Fusion Surgery2021
2021-04-08ROCHE MOLECULAR SYSTEMS, INC.$851Research paymentIn-kind items and servicescobas Influenza A/B Nucleic acid test for use on the cobas Liat System Device, Molecular DiagnosticsRD0053982021
2021-04-08Eli Lilly and Company$30Research paymentIn-kind items and servicesA RANDOMIZED, PHASE 3, OPEN LABEL TRIAL COMPARING THE EFFECT OF THE ADDITION OF TIRZEPATIDE ONCE WEEKLY VERSUS INSULIN L2021
2021-04-07E.R. Squibb & Sons, L.L.C.$193,759Research paymentCash or cash equivalentPhase I II CTLA4-NF-Probody FIH Mono Nivo Combo in advanced solid tumors2021
2021-04-07E.R. Squibb & Sons, L.L.C.$27,628Research paymentCash or cash equivalentOPDIVO Biological, OncologyPhase III Adjuvant HCC mono vs placebo2021
2021-04-04Smith+Nephew, Inc.$370Debt forgivenessCash or cash equivalentACUFEX Access Pat Pos Device, Sports Med Shoulder2021
2021-04-04Boehringer Ingelheim France S.A.S.$172Research paymentIn-kind items and servicesPh IIb dose finding vs placebo in patients with Obesity2021
2021-04-02Vitalant$2,060Compensation for services other than consulting, including serving as faculty or as a speaker at a v (3 payments)Cash or cash equivalent2021
2021-04-01Boehringer Ingelheim Pharma GmbH & Co.KG$118Research paymentIn-kind items and servicesOFEV Drug, RESPIRATORYExtension2021
2021-04-01Boehringer Ingelheim France S.A.S.$80Research paymentIn-kind items and servicesPh IIb dose finding vs placebo in patients with Obesity2021
2021-03-30ROCHE MOLECULAR SYSTEMS, INC.$2,724Research paymentIn-kind items and servicescobas Influenza A/B Nucleic acid test for use on the cobas Liat System Device, Molecular DiagnosticsRD0053982021
2021-03-26Vitalant$1,575Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2021
2021-03-18E.R. Squibb & Sons, L.L.C.$67,867Research paymentCash or cash equivalentProgressive Combinations- Metastatic ER HER2- Breast Cancer2021
2021-03-10ACUMED LLC$3,269Space rental or facility fees (teaching hospital only)Cash or cash equivalentElbow Plating System Device, Elbow2021
2021-03-08E.R. Squibb & Sons, L.L.C.$121,991Research paymentCash or cash equivalentOPDIVO Biological, Oncology2016-NIV-0532 PD-1 Immune Checkpoint Inhibition for the Prevention of Lung Cancer in Hi Risk Current and Former Smokers2021
2021-03-03Varian Medical Systems, Inc.$31,358Research paymentCash or cash equivalentImmune responses to focal therapy for early prostate cancer - U. of Colorado2021
2021-03-03Boehringer Ingelheim France S.A.S.$177Research paymentIn-kind items and servicesPh IIb dose finding vs placebo in patients with Obesity2021
2021-03-01Boehringer Ingelheim Pharma GmbH & Co.KG$122Research paymentIn-kind items and servicesOFEV Drug, RESPIRATORYExtension2021
2021-03-01Boehringer Ingelheim France S.A.S.$82Research paymentIn-kind items and servicesPh IIb dose finding vs placebo in patients with Obesity2021
2021-02-26ROCHE MOLECULAR SYSTEMS, INC.$2,724Research paymentIn-kind items and servicescobas Influenza A/B Nucleic acid test for use on the cobas Liat System Device, Molecular DiagnosticsRD0053982021
2021-02-26Vitalant$1,668Compensation for services other than consulting, including serving as faculty or as a speaker at a v (2 payments)Cash or cash equivalent2021
2021-02-19E.R. Squibb & Sons, L.L.C.$61,362Research paymentCash or cash equivalentOPDIVO Biological, OncologyPhase IIA Dara Nivo in Solid Tumors NSCLC, TNBC, PAC2021
2021-02-16EMD Millipore Corporation$2,541Royalty or LicenseCash or cash equivalent Device, DIAGNOSTIC TESTING2021
2021-02-16EMD Millipore Corporation$56Royalty or LicenseCash or cash equivalent Device, DIAGNOSTIC TESTING2021
2021-02-09E.R. Squibb & Sons, L.L.C.$120,178Research paymentCash or cash equivalentPhI II Other I-O Triplet lag3 nivo ipi vs lag3 nivo IDO2021
2021-02-09E.R. Squibb & Sons, L.L.C.$2,284Research paymentCash or cash equivalentOPDIVO Biological, OncologyPhase III 1L Gastric nivo ipi vs nivo CT vs CT2021
2021-02-02E.R. Squibb & Sons, L.L.C.$35,027Research paymentCash or cash equivalentOPDIVO Biological, OncologyPhase III NMIBC Opdivo BCG vs. BCG2021
2021-02-01EMD Millipore Corporation$15,000Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent Device, DIAGNOSTIC TESTING2021
2021-02-01Boehringer Ingelheim Pharma GmbH & Co.KG$122Research paymentIn-kind items and servicesOFEV Drug, RESPIRATORYExtension2021
2021-01-30ROCHE MOLECULAR SYSTEMS, INC.$2,724Research paymentIn-kind items and servicescobas Influenza A/B Nucleic acid test for use on the cobas Liat System Device, Molecular DiagnosticsRD0053982021
2021-01-29Eli Lilly and Company$5,270Research paymentIn-kind items and servicesA PHASE 1A/1B STUDY OF LY3484356 ADMINISTERED AS MONOTHERAPY AND IN COMBINATION WITH ABEMACICLIB TO PATIENTS WITH ER+, H2021
2021-01-26E.R. Squibb & Sons, L.L.C.$1,260Research paymentCash or cash equivalentOPDIVO Biological, OncologyPhase III RCC Monotherapy vs. everolimus ONO 4538-032021
2021-01-22Vitalant$270Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2021
2021-01-21EMD Millipore Corporation$15,000Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent Device, DIAGNOSTIC TESTING2021
2021-01-14Eli Lilly and Company$1,215Research paymentIn-kind items and servicesA PHASE 2, RANDOMIZED, PARALLEL, OPEN-LABEL COMPARATOR CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF LY32095902021
2021-01-12Biotest AG$1,701Research paymentCash or cash equivalentAn Open-label, Prospective, Multicenter Study Investigating Clinical Efficacy, Safety, and Pharmacokinetic Properties of2021
2021-01-07E.R. Squibb & Sons, L.L.C.$204,327Research paymentCash or cash equivalentOPDIVO Biological, OncologyPhase III Nivo Ipi vs Placebo in Adjuvant RCC2021
2021-01-07Premia Spine, Ltd.$4,155Research paymentCash or cash equivalentTOPSA Clinical Study to Assess the Safety and Effectiveness of the Premia Spine TOPS System2021
2021-01-05E.R. Squibb & Sons, L.L.C.$238,562Research paymentCash or cash equivalentOPDIVO Biological, OncologyPhase III Nivo ipi vs Nivo in Stage IIIb c or IV Adjuvant Melanoma2021
2021-01-05E.R. Squibb & Sons, L.L.C.$67,331Research paymentCash or cash equivalentPhase FIH CCR2-5 I II Safety Expansion2021
2021-01-05E.R. Squibb & Sons, L.L.C.$58,257Research paymentCash or cash equivalentPh III 1L Metastatic Melanoma nivo NKTR 214 vs nivo mono2021
2021-01-05E.R. Squibb & Sons, L.L.C.$42,887Research paymentCash or cash equivalentOPDIVO Biological, OncologyPhase III 1L Metastatic RCC Nivo Ipi Cabo2021
2021-01-05E.R. Squibb & Sons, L.L.C.$21,856Research paymentCash or cash equivalentOPDIVO Biological, OncologyPhase II III 1L MSS CRC Nivo SOC vs SOC2021
2021-01-04E.R. Squibb & Sons, L.L.C.$22,577Research paymentCash or cash equivalentOPDIVO Biological, OncologyPhase III Study Adj GEJ & Esoph US EU mono2021
2021-01-01Boehringer Ingelheim Pharma GmbH & Co.KG$122Research paymentIn-kind items and servicesOFEV Drug, RESPIRATORYExtension2021

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

Jefferson CountyArvada city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Arvada, CO, county Jefferson County, CO, state Colorado; placed by its city name.

MeasurePlace (city or town)
Arvada, CO
County
Jefferson County, CO
State
Colorado
Population B01003122,634579,3775,862,189
Population, 2020 census P1124,402582,9105,773,714
Median age B0100240.040.537.7
Under 18 B0100119.6%18.5%21.0%
65 and over B0100117.4%17.9%15.6%
Households B1100149,881241,7352,374,218
Foreign born B050025.6%6.3%9.8%
Median household income B19013$117,348$110,656$95,470
Median family income B19113$143,746$138,654$119,139
Per capita income B19301$59,662$60,827$52,636
Poverty rate B170015.8%6.7%9.4%
Unemployment rate B230253.8%3.9%4.6%
Civilian labor force B2302571,860336,2663,235,476
Mean commute (minutes) B0801326.126.025.2
Bachelor's degree or higher B1500351.6%52.0%45.7%
Housing units B2500152,169253,5742,589,053
Owner-occupied B2500375.3%70.7%66.2%
Renters B2500324.7%29.3%33.8%
Median home value B25077$632,600$637,600$539,400
Median gross rent B25064$1,888$1,861$1,761
White, not Hispanic B0300276.0%75.2%64.8%
Black B030021.0%1.1%3.8%
Hispanic or Latino B0300215.8%16.1%22.5%
Asian B030022.6%2.9%3.2%
American Indian and Alaska Native B030020.1%0.2%0.4%

Economy now FRED unemployment 4.1% in Sep 2026 (3.8% a year earlier); per capita personal income $86,342 in 2025, up 34% in five years (+7.3% after inflation); Unemployment rate: 3.0% in Sep 2016 to 4.1% in Sep 2026; low 2.4%, high 11.7% the state; Source: FRED, Federal Reserve Bank of St. Louis.

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Arvada, CO.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.